Neuroprotective effects of melatonin on erectile dysfunction in streptozotocin-induced diabetic rats

Area of Science:

• Neuroscience
• Endocrinology
• Urology

Background:

• Diabetic erectile dysfunction (ED) is a common complication linked to oxidative stress and neuropathy.
• Melatonin is a hormone with known antioxidant and anti-inflammatory properties.

Purpose of the Study:

• To investigate the neuroprotective effects of melatonin on erectile dysfunction in rats with streptozotocin-induced diabetes.
• To elucidate the underlying mechanisms, including oxidative stress and nerve damage.

Main Methods:

• Diabetic rats were induced using streptozotocin and treated with melatonin or a placebo.
• Erectile function, penile and major pelvic ganglion (MPG) pathology, and molecular markers of oxidative stress and inflammation were assessed.
• Key measurements included intracavernous pressure, mean arterial pressure, collagen deposition, and levels of malondialdehyde, superoxide dismutase, and p38/p-p38.

Main Results:

• Diabetic rats exhibited impaired erectile function, neuropathy in penile nerves and MPG, increased collagen, oxidative stress, and elevated p-p38 levels.
• Melatonin treatment significantly improved erectile function and ameliorated neuropathy and fibrosis in the penile tissues.
• Melatonin administration reduced oxidative stress markers and decreased p-p38 levels in diabetic rats.

Conclusions:

• Melatonin demonstrates neuroprotective effects, improving erectile function in diabetic rats.
• These benefits are likely mediated by reducing oxidative stress, inhibiting the p38 MAPK pathway, and mitigating neuropathy and fibrosis.